全文获取类型
收费全文 | 814篇 |
免费 | 70篇 |
国内免费 | 13篇 |
专业分类
儿科学 | 33篇 |
妇产科学 | 23篇 |
基础医学 | 73篇 |
口腔科学 | 5篇 |
临床医学 | 124篇 |
内科学 | 130篇 |
皮肤病学 | 11篇 |
神经病学 | 82篇 |
特种医学 | 99篇 |
外科学 | 130篇 |
综合类 | 41篇 |
一般理论 | 3篇 |
预防医学 | 46篇 |
眼科学 | 8篇 |
药学 | 45篇 |
肿瘤学 | 44篇 |
出版年
2022年 | 7篇 |
2021年 | 18篇 |
2020年 | 10篇 |
2019年 | 12篇 |
2018年 | 14篇 |
2017年 | 7篇 |
2016年 | 17篇 |
2015年 | 18篇 |
2014年 | 26篇 |
2013年 | 28篇 |
2012年 | 32篇 |
2011年 | 28篇 |
2010年 | 16篇 |
2009年 | 27篇 |
2008年 | 30篇 |
2007年 | 44篇 |
2006年 | 27篇 |
2005年 | 24篇 |
2004年 | 25篇 |
2003年 | 34篇 |
2002年 | 21篇 |
2001年 | 18篇 |
2000年 | 15篇 |
1999年 | 29篇 |
1998年 | 26篇 |
1997年 | 23篇 |
1996年 | 35篇 |
1995年 | 29篇 |
1994年 | 20篇 |
1993年 | 18篇 |
1992年 | 15篇 |
1991年 | 19篇 |
1990年 | 12篇 |
1989年 | 22篇 |
1988年 | 26篇 |
1987年 | 15篇 |
1986年 | 11篇 |
1985年 | 14篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1976年 | 6篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1971年 | 3篇 |
1966年 | 4篇 |
排序方式: 共有897条查询结果,搜索用时 15 毫秒
41.
42.
43.
Multispectral analysis of magnetic resonance images 总被引:1,自引:0,他引:1
Magnetic resonance (MR) imaging systems produce spatial distribution estimates of proton density, relaxation time, and flow, in a two dimensional matrix form that is analogous to that of the image data obtained from multispectral imaging satellites. Advanced NASA satellite image processing offers sophisticated multispectral analysis of MR images. Spin echo and inversion recovery pulse sequence images were entered in a digital format compatible with satellite images and accurately registered pixel by pixel. Signatures of each tissue class were automatically determined using both supervised and unsupervised classification. Overall tissue classification was obtained in the form of a theme map. In MR images of the brain, for example, the classes included CSF, gray matter, white matter, subcutaneous fat, muscle, and bone. These methods provide an efficient means of identifying subtle relationships in a multi-image MR study. 相似文献
44.
45.
Meagher EA 《Current pharmaceutical design》2004,10(6):603-611
A group of chemical mediators, the eicosanoids, is critical players in a multitude of physiological processes. Generated by the action of the cyclooxygenase (COX) enzyme on arachidonic acid they are responsible for diverse and often opposing actions such as platelet function, vasomotor tone, gastric cytoprotection and inflammation. Since their discovery several decades ago, our knowledge concerning their synthesis, function as natural ligands and methods to manipulate their activity through drug development has expanded. Traditional Non Steroidal Anti-Inflammatory Drugs (NSAIDs) are nonselective inhibitors of the COX enzyme, of which two isoforms are known to exist - COX-1 and COX-2. NSAIDs have been the mainstay of treatment in the management of pain and inflammation associated with acute and chronic inflammatory conditions that affect more than 10 million Americans. Their efficacy in this regard is not questioned. However, gastrointestinal toxicity arising from chronic NSAID ingestion is common and limits their use in clinical practice. Gastrointestinal toxicity has been attributed to the blockade of the COX-1 mediated generation of the cytoprotective prostanoids, such as PGE(2) and PGI(2). Selective COX-2 inhibitors were designed to inhibit the production of COX-2 dependent inflammatory prostanoids and to leave intact the cytoprotective COX-1 products. The first of a new class of these selective COX-2 inhibitors - the coxibs- were introduced to the market in 1999. These compounds, while exhibiting similar efficacy to traditional NSAIDs, were associated with a reduced incidence of surrogate or actual indices of GI toxicity. Questions have been raised concerning the cardiovascular and renal profiles of these agents based on data from both small and large clinical studies. More recently, our increasing understanding of the relative contributions of both isoforms of the COX enzyme to individual components of vascular homeostais has allowed us to appreciate the cardiovascular and renovascular implications of selective COX-2 inhibition. 相似文献
46.
Meagher DJ Quinn JF Bourke S Linehan S Murphy P Kinsella A Mullaney J Waddington JL 《Psychiatry research》2004,126(3):217-227
There remains uncertainty regarding any progressive nature of psychopathology and cognitive dysfunction in late-stage schizophrenia, and whether duration of initially untreated psychosis (DUP) might be associated with such 'progression'. This study examines longitudinally, over 3 years, the psychopathology and neuropsychology in 82 inpatients with DSM-IV schizophrenia, many of whom were admitted in the pre-neuroleptic era. Increase in executive dysfunction exceeded that in general cognitive impairment. Positive but not negative symptom severity decreased modestly; the primary predictor of negative symptom severity was DUP. On index assessment, psychopathology evidenced a three-factor structure; at follow-up, psychomotor poverty evidenced greater prominence and cohesion, and was on both occasions predicted primarily by DUP, while reality distortion was altered and disorganisation disassembled into alternative elements. It would appear that as years of chronic, refractory illness accrue, psychomotor poverty becomes more sharply delineated and dominant within the overall structure of psychopathology, and its prominence is predicted enduringly by DUP. 相似文献
47.
48.
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme 总被引:6,自引:0,他引:6
Rayner CR Forrest A Meagher AK Birmingham MC Schentag JJ 《Clinical pharmacokinetics》2003,42(15):1411-1423
OBJECTIVE: To characterise the pharmacokinetic-pharmacodynamic relationships for linezolid efficacy. DESIGN AND STUDY POPULATION: Retrospective nonblinded analysis of severely debilitated adult patients with numerous comorbid conditions and complicated infections enrolled under the manufacturer's compassionate use programme. METHODS: Patients received intravenous or oral linezolid 600 mg every 12 hours. Plasma concentrations were obtained and a multicompartmental pharmacokinetic model was fitted. Numerical integration of the fitted functions provided the area under the concentration-time curve over 24 hours (AUC), the ratio of AUC to minimum inhibitory concentration (AUC/MIC) and the percentage of time that plasma concentrations exceeded the MIC (%T>MIC). MAIN OUTCOME MEASURES: Modelled pharmacodynamic outcomes of efficacy included probabilities of eradication and clinical cure (multifactorial logistic regression, nonparametric tree-based modelling, nonlinear regression) and time to bacterial eradication (Kaplan-Meier and Cox proportional hazards regression). Factors considered included AUC/MIC, %T>MIC, site of infection, bacterial species and MIC, and other medical conditions.RESULTS: There were 288 cases evaluable by at least one of the efficacy outcomes. Both %T>MIC and AUC/MIC were highly correlated (Spearman r2 = 0.868). In our analyses, within specific infection sites, the probability of eradication and clinical cure appeared to be related to AUC/MIC (eradication: bacteraemia, skin and skin structure infection [SSSI], lower respiratory tract infection [LRTI], bone infection; clinical cure: bacteraemia, LRTI) and %T>MIC (eradication: bacteraemia, SSSI, LRTI; clinical cure: bacteraemia, LRTI). Time to bacterial eradication for bacteraemias appeared to be related to the AUC, %T>MIC and AUC/MIC. For most sites, AUC/MIC and %T>MIC models performed similarly. CONCLUSIONS: Higher success rates for linezolid may occur at AUC/MIC values of 80-120 for bacteraemia, LRTI and SSSI. Chance of success in bacteraemia, LRTI and SSSI also appear to be higher when concentrations remain above the MIC for the entire dosing interval. 相似文献
49.
Butler MW Mullan RH Schaffer KE Crotty TB Luke DA Donnelly SC 《Irish journal of medical science》2003,172(4):204-205
Background Hydatid disease is rare in Ireland and its incidence and prevalence are unknown. Most cases are diagnosed by a combination
of clinical findings, morphological features on imaging and by serological testing.
Aims We describe an Irish case of pulmonary hydatid disease detected at bronchoscopy by bronchoalveolar lavage, and discuss the
diagnosis and treatment of the disorder. 相似文献
50.
No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study 总被引:5,自引:0,他引:5
Morris DW McGhee KA Schwaiger S Scully P Quinn J Meagher D Waddington JL Gill M Corvin AP 《Schizophrenia Research》2003,60(2-3):167-172
A recent family-based association study identified a putative association between variants in the dystrobrevin binding protein 1 (dysbindin) gene (DTNBP1) and schizophrenia. This study used a sample of 270 Irish pedigrees multiply affected with schizophrenia. We attempted to replicate these findings in an independent Irish sample of 219 schizophrenia cases and 231 controls. No evidence was found to suggest an association between the DTNBP1 gene and schizophrenia in our sample. Possible reasons for these findings are discussed. 相似文献